Establishment and Characterization of Doxorubicin-Resistant Human Bladder Cancer Cell Line, Kk47/adm
Author:
Affiliation:
1. From the Department of Urology, Faculty of Medicine, Kyushu University, Fukuoka
2. Institute of Applied Microbiology, University of Tokyo, Tokyo, Japan
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference20 articles.
1. MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium;Sternberg;J Urol.,1988
2. An overview of intravesical therapy for superficial bladder tumors;Harry;J. Urol.,1987
3. In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia;Johnson;Cancer Treat. Rep.,1978
4. Isolation and preliminary characterization of an adriamycin-resistant murine fibrosarcoma cell line;Giavazzi;Cancer Res.,1983
5. Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA;Graydon;Cancer Res.,1985
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Palmatine sensitizes chemoresistant triple negative breast cancer cells via efflux inhibition of multidrug resistant protein 1.;Scientific African;2021-11
2. Establishment of Drug-resistant Cell Lines as a Model in Experimental Oncology: A Review;Anticancer Research;2019-12
3. Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells;Free Radical Biology and Medicine;2019-09
4. Overexpression of REIC/Dkk-3 suppresses the expression of CD147 and inhibits the proliferation of human bladder cancer cells;Oncology Letters;2017-07-08
5. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro;BMC Cancer;2015-11-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3